NL-OMON53661尚未招募不适用
Biomarker based intervention strategies to combat adverse effects of shift work - GRIP
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •Age 18 to 60 years.
- •Work at least 4 night shifts a month on average.
- •Shift workers, working rotating shifts (morning, evening and night shifts) or
- •working predominantly night shifts. Night shift defined as work at least 1
- •hours between 0:00- and 6:00.
- •Work at least 2 night shifts in a row
- •Work >= 20 work hours per week.
- •Having a shift duration of 6 h-12 h.
- •History of >= 1 year of working rotating shift work or night shifts prior to
排除标准
- •Taking medication that the investigator believes would interfere with the
- •objectives of the study. For example, sleep medication, medication that
- •interferes with glucose homeostasis, and/or anti-inflammatory drugs.
- •Pregnant or have a wish to become pregnant during the study period.
- •Planned surgery during the entire study period
- •Alcohol consumption > 21 units/week
- •Severe psychiatric disease and/or any mental or physical disability that will
- •hinder participation in the interventions
- •Severe cardiovascular disease, to the discretion of the study doctor
- •Having a chronic inflammatory disease, including asthma, rheumatic fever,
- •Other bowel diseases, including Chron*s disease and Colitis Ulcerosa.
- •A disease or condition with higher bleeding risk (/risk of hemorrhage), under
- •which a blood sample may lead to complications.
- •Participation in any clinical trial including blood sampling and/or
- •administration of substances up to 90 days before Day 01 of this study
- •Recent blood donation (<1 month prior to the start of the study)
研究者
相似试验
已完成
4 期
Biomarker-guided treatment-and-stop-strategy for recombinant IL-1receptor antagonist (anakinra) in patients with systemic Juvenile Idiopathic Arthritis.Still's diseasesystemic JIA1000381610023213NL-OMON43845niversitair Medisch Centrum Utrecht55
进行中（未招募）
1 期
Biomarker-guided treatment-and-stop-strategy for short acting IL-1 blockade in patients with systemic Juvenile Idiopathic Arthritis.systemic Juvenile Idiopathic ArthritisEUCTR2015-004393-16-NLniversity Medical Center Utrecht
进行中（未招募）
2 期
Genetic, immune and treatment-related differences in cancers of the mouth and throat in India.CTRI/2020/10/028482ational Institutes of Health USA
招募中
不适用
Biomarker discovery and development of therapy for aortic aneurysmAortic aneurysmJPRN-UMIN000010927Yokohama City University Graduate School of Medicine150
招募中
Unknown
Identification of biomarkers in patients with diabetic macular edemaJPRN-jRCT1080223989SANTEN PHARMACEUTICAL CO., LTD.36